Dow Jones

40 211,72

0,53%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Guidant Corp (GDT)
Guidant Corp (GDT) Actualités

GDT

Guidant (GDT)

Guidant Corp

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:GDT

<< Précédent 1 2 3 4 5 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
25/01/2006	13h00	Business Wire	Guidant Terminates Johnson & Johnson Agreement; Cancels Special Meeting of Shareholders; Enters Into Agreement with Boston Scien	NYSE:GDT	Guidant Corp
24/01/2006	21h41	Business Wire	Guidant Receives Recommendation for Approval from European Competent Authority for Drug Eluting Stent; Company Has Successfully	NYSE:GDT	Guidant Corp
23/01/2006	17h00	Business Wire	Guidant Updates Worldwide Physician Communication Regarding Important Safety Information About Certain Pacemakers	NYSE:GDT	Guidant Corp
19/01/2006	15h48	PR Newswire (US)	New York Times to Intervene in Texas Defibrillator Case; Attorney Bob Hilliard Welcomes Newspaper in Guidant Corp. Lawsuit	NYSE:GDT	Guidant Corp
17/01/2006	23h02	PR Newswire (US)	Boston Scientific Acknowledges Guidant Board's Decision	NYSE:GDT	Guidant Corp
17/01/2006	22h27	Business Wire	Guidant Concludes Boston Scientific Offer is Superior	NYSE:GDT	Guidant Corp
17/01/2006	15h33	Business Wire	Guidant Receives Amended Offer from Boston Scientific Guidant's Board to Evaluate Offer	NYSE:GDT	Guidant Corp
17/01/2006	13h59	PR Newswire (US)	Boston Scientific Announces Offer to Acquire Guidant at $80 Per Share	NYSE:GDT	Guidant Corp
14/01/2006	01h05	PR Newswire (US)	Guidant Corporation and Johnson & Johnson Announce New Definitive Acquisition Agreement	NYSE:GDT	Guidant Corp
13/01/2006	19h04	PR Newswire (US)	/K I L L K I L L K I L L -- Boston Scientific Corporation/	NYSE:GDT
13/01/2006	18h44	PR Newswire (US)	Boston Scientific Agrees to Two-Hour Extension	NYSE:GDT	Guidant Corp
13/01/2006	04h04	Business Wire	Guidant Receives Amended Offer from Boston Scientific; Guidant's Board to Evaluate Offer	NYSE:GDT	Guidant Corp
13/01/2006	01h21	PR Newswire (US)	Boston Scientific Improves Offer to Acquire Guidant	NYSE:GDT	Guidant Corp
12/01/2006	22h14	PR Newswire (US)	Elliott Associates Strongly Disagrees With Guidant's Decision To Accept Johnson & Johnson Lower Offer	NYSE:GDT	Guidant Corp
12/01/2006	02h21	PR Newswire (US)	Boston Scientific Comments on Johnson & Johnson's Amended Agreement to Acquire Guidant	NYSE:GDT	Guidant Corp
10/01/2006	15h56	PR Newswire (US)	Elliott Associates Believes Guidant Bid by Boston Scientific Superior to Johnson & Johnson Offer	NYSE:GDT	Guidant Corp
10/01/2006	14h37	Business Wire	Guidant Announces Preliminary, Unaudited 2005 Fourth Quarter Sales; Guidant Receives Anticipated FDA Follow-up Letter; No New Ob	NYSE:GDT	Guidant Corp
09/01/2006	00h14	Business Wire	Guidant Receives Definitive Offer From Boston Scientific; Guidant's Board to Evaluate Offer	NYSE:GDT	Guidant Corp
28/12/2005	22h24	PR Newswire (US)	Johnson & Johnson and Guidant Corporation Proposed Merger Registration Statement Declared Effective	NYSE:GDT	Guidant Corp
05/12/2005	14h00	PR Newswire (US)	Boston Scientific Proposes to Acquire Guidant for $72 Per Share in Cash and Stock; Transaction Valued at $25 Billion	NYSE:GDT	Guidant Corp
02/12/2005	21h45	PR Newswire (US)	Provost Umphrey, LLP Files Securities Fraud Class Action Against Guidant Corporation	NYSE:GDT	Guidant Corp
19/11/2005	03h18	PR Newswire (US)	Shareholder Lawsuit Filed Against Guidant Corporation, Berman DeValerio Pease Tabacco Burt & Pucillo Says	NYSE:GDT	Guidant Corp
15/11/2005	16h59	Business Wire	Guidant Reports Excellent 12-Month Results from SPIRIT FIRST Everolimus Eluting Coronary Stent Clinical Trial; Results Demonstra	NYSE:GDT	Guidant Corp
15/11/2005	13h12	Business Wire	Guidant Appoints Board Chairman James M. Cornelius as Interim Chief Executive Officer; Ronald W. Dollens Retires after 11 Years	NYSE:GDT	Guidant Corp
15/11/2005	13h00	PR Newswire (US)	Johnson & Johnson and Guidant Corporation Announce Revised Acquisition Agreement with Net Value of $19 Billion	NYSE:GDT	Guidant Corp
10/11/2005	17h22	Business Wire	Guidant Completes Enrollment in International Drug Eluting Stent Clinical Trial; Data from Study Will Support Launch of XIENCE V	NYSE:GDT	Guidant Corp
09/11/2005	15h12	Business Wire	Guidant Announces Publication of Enhanced Product Performance Report; Cardiac Rhythm Management Report Delivers Unprecedented Le	NYSE:GDT	Guidant Corp
08/11/2005	23h00	PR Newswire (US)	Shareholder Class Action Filed Against Guidant Corporation By The Law Firm Of Schiffrin & Barroway, LLP	NYSE:GDT	Guidant Corp
08/11/2005	21h16	Business Wire	Guidant Commissions Team of Experts to Review Life Cycle of Product Development; Design for Reliability Team Reflects Company Co	NYSE:GDT	Guidant Corp
08/11/2005	18h03	Business Wire	Guidant Announces Fourth Quarter Dividend	NYSE:GDT	Guidant Corp